The effect of estrogen in coronavirus disease 2019

Am J Physiol Lung Cell Mol Physiol. 2021 Jul 1;321(1):L219-L227. doi: 10.1152/ajplung.00332.2020. Epub 2021 May 5.

Abstract

The outcomes of coronavirus disease 2019 (COVID-19) vary between men and women. Some statistical reports have shown that men have a higher risk of developing COVID-19 and suffer from worse outcomes than females. Although there are many factors that can explain the high prevalence of COVID-19 in men, such as lifestyle habits and the different profile of comorbidities among sexes, the distinctions between male and female immune systems cannot be ignored. It has been sufficiently shown that sex differences have a critical influence on the shaping of immune response, which then leads to different pathogenesis in infectious diseases. Compared with males, females typically have a more effective innate and adaptive immune response to viral infections in COVID-19. What's more, there is a growing body of evidence showing that estrogen exerts an effect on the regulation of immune response. This article examines the effect and mechanism of estrogen on COVID-19.

Keywords: COVID-19; SARS-CoV-2; estrogen; immune response; sex difference.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adaptive Immunity*
  • COVID-19 / immunology*
  • Estrogens / immunology*
  • Female
  • Humans
  • Immunity, Innate*
  • Male
  • SARS-CoV-2 / immunology*
  • Sex Characteristics*

Substances

  • Estrogens